Concepedia

Alberto Arranz

AA

14

Publications

766

Citations

13

H-Index

2004

Active since

Affiliations

Hospital Universitario Príncipe de Asturias(Current)

Instituto Ramón y Cajal de Investigación Sanitaria

Universidad de Alcalá

Universidad Complutense de Madrid

Universidad Autónoma de Madrid

Alberto Arranz is an author at Hospital Universitario Príncipe de Asturias specializing in epidemiology, primary immunodeficiency, and immunology.

ORCID

Top concepts

Publications per year

2004–2023

14

Publications

14

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV

Federico Pulido, José Ramón Arribas, Rafaël Delgado et al. · AIDS · 2008 · 154 citations

Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression

José Ramón Arribas, Federico Pulido, Rafaël Delgado et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 149 citations

Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis

José Ramón Arribas, Rafaël Delgado, Alberto Arranz et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 108 citations · Full text

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron et al. · The Lancet HIV · 2020 · 68 citations · Full text

, , +9

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

Federico Pulido, Ignacio Valero, Rafaël Delgado et al. · Antiviral Therapy · 2009 · 60 citations · Full text

Rows per page

1–5 of 14